|
|
|
Saturday, March 1, 2008 — 7:00 PM, Convention Center 201/203
|
- Applications of Molecular Analysis to Small Biopsy and Cytology Specimens for Diagnosis and Targeted Therapy: What the Practicing Pathologist Needs to Know
|
|
Moderator:
|
Martha B. Pitman, Massachusetts General Hospital and Harvard Medical School, Boston, MA
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. Dr. Mark H. Stoler indicated he is a consultant for Merck, Qiagen, Ventana and Roche Molecular. Dr. Kevin Halling indicated he receives royalties from Abbott Laboratories for sale of UroVysion and LAVysion probe sets that are used to detect bladder cancer and lung cancer, respectively, in cytologic specimens. In addition, Dr. Kevin Halling receives grant funding from Abbott Labs (Abbott Molecular) for development of FISH assays. All other faculty members for this Symposium have indicated they have no disclosures to make.
|
Click the button above to add this event to your Itinerary Planner...
 Click here to view (or print) handout in single page format for the entire meeting.
Note: Any slides will be printed in color.
Click any blue title below to display and print the handout for individual lecture(s):
| 7:00 | Introduction - Martha B. Pitman, Massachusetts General Hospital and Harvard Medical School, Boston, MA |
| 7:15 | Molecular Diagnostics and New Molecular Predictive Markers in Limited Material: An Overview - Marc Ladanyi, Memorial Sloan-Kettering Cancer Center, New York, NY |
| 7:30 | EGFR, Lung Cancer and Cytology - Maureen Zakowski, Memorial Sloan-Kettering Cancer Center, New York, NY |
| 8:00 | Her2/neu Analysis on FNA Smears and Core Biopsies of Primary and Metastatic Breast Cancer - Ann Thor, University of Colorado at Denver and Health Sciences Center, Aurora, CO |
| 8:30 | The Utility of HPV Testing: A Diagnostic, Prognostic and Predictive Marker - Mark H. Stoler, University of Virginia Health System, Charlottesville, VA |
| 9:00 | Bladder Cancer Detection Using FISH (UroVysion Assay) - Kevin Halling, Mayo Clinic, Rochester, MN |
|
|
|
